위암 수술 환자의 건강결과 측정을 위한 동반상병 측정도구의 유용성 연구
Usefulness of Comorbidity Indices in Operative Gastric Cancer Cases
0
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Objectives : The purpose of the current study was to evaluate the usefulness of the following four comorbidity indices in gastric cancer patients who underwent surgery: Charlson Comorbidity Index (CCI), Cumulative Illness rating scale (CIRS), Index of Co-existent Disease (ICED), and Kaplan-Feinstein Scale (KFS). Methods : The study subjects were 614 adults who underwent surgery for gastric cancer at K hospital between 2005 and 2007. We examined the test-retest and inter-rater reliability of 4 comorbidity indices for 50 patients. Reliability was evaluated with Spearman rho coefficients for CCI and CIRS, while Kappa values were used for the ICED and KFS indices. Logistic regression was used to determine how these comorbidity indices affected unplanned readmission and death. Multiple regression was used for determining if the comorbidity indices affected length of stay and hospital costs. Results : The test-retest reliability of CCI and CIRS was substantial (Spearman rho=0.746 and 0.775, respectively), while for ICED and KFS was moderate (Kappa=0.476 and 0.504, respectively). The inter-rater reliability of the CCI, CIRS, and ICED was moderate (Spearman rho=0.580 and 0.668, and Kappa=0.433, respectively), but for KFS was fair (Kappa=0.383). According to the results from logistic regression, unplanned readmissions and deaths were not significantly different between the comorbidity index scores. But, according to the results from multiple linear regression, the CIRS group showed a significantly increased length of hospital stay (p<0.01). Additionally, CCI showed a significant association with increased hospital costs (p<0.01). Conclusions : This study suggests that the CCI index may be useful in the estimation of comorbidities associated with hospital costs, while the CIRS index may be useful where estimatation of comorbiditie associated with the length of hospital stay are concerned.
Abstract
Objectives : The purpose of the current study was to evaluate the usefulness of the following four comorbidity indices in gastric cancer patients who underwent surgery: Charlson Comorbidity Index (CCI), Cumulative Illness rating scale (CIRS), Index of Co-existent Disease (ICED), and Kaplan-Feinstein Scale (KFS). Methods : The study subjects were 614 adults who underwent surgery for gastric cancer at K hospital between 2005 and 2007. We examined the test-retest and inter-rater reliability of 4 comorbidity indices for 50 patients. Reliability was evaluated with Spearman rho coefficients for CCI and CIRS, while Kappa values were used for the ICED and KFS indices. Logistic regression was used to determine how these comorbidity indices affected unplanned readmission and death. Multiple regression was used for determining if the comorbidity indices affected length of stay and hospital costs. Results : The test-retest reliability of CCI and CIRS was substantial (Spearman rho=0.746 and 0.775, respectively), while for ICED and KFS was moderate (Kappa=0.476 and 0.504, respectively). The inter-rater reliability of the CCI, CIRS, and ICED was moderate (Spearman rho=0.580 and 0.668, and Kappa=0.433, respectively), but for KFS was fair (Kappa=0.383). According to the results from logistic regression, unplanned readmissions and deaths were not significantly different between the comorbidity index scores. But, according to the results from multiple linear regression, the CIRS group showed a significantly increased length of hospital stay (p<0.01). Additionally, CCI showed a significant association with increased hospital costs (p<0.01). Conclusions : This study suggests that the CCI index may be useful in the estimation of comorbidities associated with hospital costs, while the CIRS index may be useful where estimatation of comorbiditie associated with the length of hospital stay are concerned.
참고문헌 (31)
- Yoon SJ, "Introduction to health care outcomes research", J Korean Soc Qual Assur Health Care, 13(1), pp.9~12 (2007)
- Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation", J Chronic Dis, 40(5), pp.373~383 (1987)
- Sundararajan V, "New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality", J Clin Epidemiol, 57(12), pp.1288~1294 (2004)
- Ahn HS, "Association between unplanned readmission rate and volume of breast cancer operation cases", Int J Clin Pract, 60(1), pp.32~35 (2006)
- Extermann M, "Measuring comorbidity in older cancer patients", Eur J Cancer, 36(4), pp.453~471 (2000)
- Librero J, "Chronic comorbidity and outcomes of hospital care: Length of stay, mortality, and readmission at 30 and 365 days", J Clin Epidemiol, 52(3), pp.171~179 (1999)
- Lubke T, "Does Charlsoncomorbidity index correlate with short-term outcome in patients with gastric cancer?", Zentralbl Chir, 128(11), pp.970~976 (2003)
- Yokota T, "Prognostic factors for gastric cancer in the elderly", Eur J Surg Oncol, 27(5), pp.451~453 (2001)
- Klabunde CN, "Development of a comorbidity index using physician claims data", J Clin Epidemiol, 53(12), pp.1258~1267 (2000)
- Corser W, "Concordance between comorbidity data from patient selfreport interviews and medical record documentation", BMC Health Serv Res, 8, pp.85~85 (2008)
- de Groot V, "How to measure comorbidity: A critical review of available methods", J Clin Epidemiol, 56(3), pp.221~229 (2003)
- Extermann M, "Comorbidity and functional status are independent in older cancer patients", J Clin Oncol, 16(4), pp.1582~1587 (1998)
- Landis JR, "The measurement of observer agreement for categorical data", Biometrics, 33(1), pp.159~174 (1977)
- Hall SF, "Interrater reliability of measurements of comorbid illness should be reported", J Clin Epidemiol, 59(9), pp.926~933 (2006)
- Katz JN, "Can comorbidity be measured by questionnaire rather than medical record review?", Med Care, 34(1), pp.73~84 (1996)
- Hudon C, "Cumulative illness rating scale was a reliable and valid index in a family practice context", J Clin Epidemiol, 58(6), pp.603~608 (2005)
- Imamura K, "Reliability of a comorbidity measure: The index of co-existent disease (ICED)", J Clin Epidemiol, 50(9), pp.101l~1016 (1997)
- Newschaffer CJ, "Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data", J Clin Epidemiol, 50(6), pp.725~733 (1997)
- Rochon PA, "Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability: A prospective comparison of three comorbidity indices", Med Care, 34(11), pp.1093~1101 (1996)
- Greenfield S, "Patterns of care related to age of breast cancer patients", JAMA, 257(20), pp.2766~2770 (1987)
- Charlson M, "Can disease management target patients most likely to generate high costs? The impact of comorbidity", J Gen Intern Med, 22(4), pp.464~469 (2007)
- Shah AN, "Comorbid illness affects hospital costs related to hip arthroplasty. Quantification of health status and implications for fair reimbursement and surgeon comparisons", J Arthroplasty, 19(6), pp.700~705 (2004)
- Kieszak SM, "A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data", J Clin Epidemiol, 52(2), pp.137~142 (1999)
- Luthi JC, "Administrative data outperformed single-day chart review for comorbidity measure", Int J Qual Health Care, 19(4), pp.225~231 (2007)
- Kane RL, "Understanding Health Care Outcomes Research", pp.219~263 (2006), Jones and Bartlett
- Gasparini G, "Clinical and prognostic aspects of gastric carcinoma in the elderly", J Gastrointest Surg, 10(3), pp.395~401 (2006)
- Nagel G, "The impact of comorbidity on the survival of postmenopausal women with breast cancer", J Cancer Res Clin Oncol, 130(11), pp.664~670 (2004)
- Yan Y, "Comorbidity indices to predict mortality from medicare data: Results from the national registry of atrial fibrillation", Med Care, 43(11), pp.1073~1077 (2005)
- Fortin M, "Comparative assessment of three different indices of multimorbidity for studies on health-related quality of life", Health Qual Life Outcomes, 3, pp.74~ (2005)
- 임선희, "국가 암 발생 데이터베이스에 등록된 암환자의 연령군별 생존율: 기간 분석 방식에 의한 1997년과 2002년도 생존율 비교", 예방의학회지, 41(1), pp.17~22 (2008), 대한예방의학회
- 신해림, "암등록과 암관리사업의 최신 국제 경향 및 우리나라 암발생 통계", 예방의학회지, 41(2), pp.84~91 (2008), 대한예방의학회